Depreciation of Arcadia Biosciences, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Arcadia Biosciences, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Arcadia Biosciences, Inc. Depreciation for the quarter ending 30 Sep 2025 was $2,000, a 71% decline year-over-year.
  • Arcadia Biosciences, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $13,000.
  • Arcadia Biosciences, Inc. annual Depreciation for 2024 was $58,000, a 48% decline from 2023.
  • Arcadia Biosciences, Inc. annual Depreciation for 2023 was $111,000, a 75% decline from 2022.
  • Arcadia Biosciences, Inc. annual Depreciation for 2022 was $439,000, a 53% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Arcadia Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,000 $2,000 -$5,000 -71% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $18,000 $15,000 -$2,000 -12% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $20,000 $13,000 -$38,000 -75% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $58,000 $17,000 +$61,000 +78% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q3 2024 $3,000 $7,000 -$82,000 -92% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $79,000 $17,000 -$12,000 -41% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $91,000 $51,000 -$20,000 -28% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $111,000 $78,000 -$163,000 -192% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 $274,000 $89,000 +$12,000 +16% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $262,000 $29,000 -$99,000 -77% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $361,000 $71,000 -$78,000 -52% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $439,000 $85,000 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $77,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $128,000 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $149,000 -$87,000 -37% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $236,000 +$162,000 +219% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $74,000 +$40,000 +118% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $34,000 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1

Arcadia Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $58,000 -$53,000 -48% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
2023 $111,000 -$328,000 -75% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $439,000 -$490,000 -53% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $929,000 +$297,000 +47% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $632,000 +$438,000 +226% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $194,000 +$40,000 +26% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $154,000 -$125,000 -45% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2020 2019 FY
2017 $279,000 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.